| 1. |
Davis, H. L., Michel, M. L., and Whalen, R. G. (1993) DNA-based immunization induces continuous secretion of hepatitis B surface
antigen and high levels of circulating antibody. Hum. Mol. Genet.
2, 1847.
|
| |
| 2. |
Tang, D. C., DeVit, M., and Johnston, S. A. (1992) Genetic immunization is a simple method for eliciting an immune response.
Nature
356, 152.
|
| |
| 3. |
Wang, B., Boyer, J., Srikantan, V., et al. (1993) DNA inoculation induces neutralizing immune responses against human immunodeficiency
virus type 1 in mice and nonhuman primates. DNA Cell Biol.
12, 799.
|
| |
| 4. |
Xiang, Z. Q., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J., and Ertl, H. C. (1994) Vaccination with a plasmid vector
carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology
199, 132.
|
| |
| 5. |
Michel, M. L., Davis, H. L., Schleef, M., Mancini, M., Tiollais, P., and Whalen, R. G. (1995) DNA-mediated immunization to
the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA
92, 5307.
|
| |
| 6. |
Yankauckas, M. A., Morrow, J. E., Parker, S. E., et al. (1993) Long-term anti-nucleoprotein cellular and humoral immunity
is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol.
12, 771.
|
| |
| 7. |
Robinson, H. L., Hunt, L. A., and Webster, R. G. (1993) Protection against a lethal influenza virus challenge by immunization
with a haemagglutinin-expressing plasmid DNA. Vaccine
11, 957.
|
| |
| 8. |
Wolff, J. A., Malone, R. W., Williams, P., et al. (1990) Direct gene transfer into mouse muscle in vivo. Science
247, 1465.
|
| |
| 9. |
Manickan, E., Yu, Z., Rouse, R. J., Wire, W. S., and Rouse, B. T. (1995) Induction of protective immunity against herpes simplex
virus with DNA encoding the immediate early protein ICP 27. Viral Immunol.
8, 53.
|
| |
| 10. |
Donnelly, J. J., Martinez, D., Jansen, K. U., Ellis, R. W., Montgomery, D. L., and Liu, M. A. (1996) Protection against papillomavirus
with a polynucleotide vaccine. J. Infect. Dis.
173, 314.
|
| |
| 11. |
Yokoyama, M., Zhang, J., and Whitton, J. L. (1995) DNA immunization confers protection against lethal lymphocytic choriomeningitis
virus infection. J. Virol.
69, 2684.
|
| |
| 12. |
Phillpotts, R. J., Venugopal, K., and Brooks, T. (1996) Immunisation with DNA polynucleotides protects mice against lethal
challenge with St. Louis encephalitis virus. Arch. Virol.
141, 743.
|
| |
| 13. |
Ulmer, J. B., Donnelly, J. J., Parker, S. E., et al. (1993) Heterologous protection against influenza by injection of DNA
encoding a viral protein. Science
259, 1745.
|
| |
| 14. |
Huygen, K., Content, J., Denis, O., et al. (1996) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med.
2, 893.
|
| |
| 15. |
Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D., and Lowrie, D. B. (1996) Vaccination against tuberculosis
by DNA injection. Nat. Med.
2, 888.
|
| |
| 16. |
Xu, D. and Liew, F. Y. (1995) Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein,
gp63, of L. major. Immunology
84, 173.
|
| |
| 17. |
Sedegah, M., Hedstrom, R., Hobart, P., and Hoffman, S. L. (1994) Protection against malaria by immunization with plasmid DNA
encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA
91, 9866.
|
| |
| 18. |
Doolan, D. L., Sedegah, M., Hedstrom, R. C., Hobart, P., Charoenvit, Y., and Hoffman, S. L. (1996) Circumventing genetic restriction
of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med.
183, 1739.
|
| |
| 19. |
Niedrig, M., Rabanus, J. P., L’Age Stehr, J., Gelderblom, H. R., and Pauli, G. (1988) Monoclonal antibodies directed against
human immunodeficiency virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency
virus. J. Gen. Virol.
69, 2109.
|
| |
| 20. |
Mitsudomi, T., Viallet, J., Mulshine, J. L., Linnoila, R. I., Minna, J. D., and Gazdar, A. F. (1991) Mutations of ras genes
distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene
6, 1353.
|
| |
| 21. |
Graham, F. L. and Eb, A. J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology
52, 456.
|
| |
| 22. |
Wolf, H., Modrow, S., Soutschek, E., Motz, M., Grunow, R., and Döbl, H. (1990) Production, mapping and biological characterisation
of monoclonal antibodies to the core protein (p24) of the human immunodeficiency virus type 1. AIFO
1, 24.
|
| |
| 23. |
Wagner, R., Deml, L., Fliessbach, H., Wanner, G., and Wolf, H. (1994) Assembly and extracellular release of chimeric HIV-1
Pr55gag retrovirus-like particles. Virology
200, 162.
|
| |
| 24. |
Sharp, P. M. and Li, W. H. (1987) The codon adaptation Index—a measure of directional synonymous codon usage bias, and its
potential applications. Nucleic Acids Res.
15, 1281.
|
| |
| 25. |
Graf, M., Bojak, A., Deml, L., Bieler, K., Wolf, H., and Wagner, R. (2000) Concerted action of multiple cis-acting sequences
is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J. Virol.
74, 10822.
|
| |
| 26. |
Wagner, R., Graf, M., Bieler, K., et al. (2000) Rev-independent expression of synthetic gag-pol genes of human immunodeficiency
virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum. Gene Ther.
11, 2403.
|
| |
| 27. |
Haas, J., Park, E. C., and Seed, B. (1996) Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol.
6, 315.
|
| |
| 28. |
Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K., and Pavlakis, G. N. (1992): Mutational inactivation
of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol.
66, 7176.
|
| |
| 29. |
Schneider, R., Campbell, M., Nasioulas, G., Felber, B. K., and Pavlakis, G. N. (1997) Inactivation of the human immunodeficiency
virus type 1 inhibitory elements allows Revindependent expression of Gag and Gag/protease and particle formation. J. Virol.
71, 4892.
|
| |
| 30. |
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1993) DNA vaccines: protective
immunizations by parenteral, mucosal, and genegun inoculations. Proc. Natl. Acad. Sci. USA
90, 11478.
|
| |
| 31. |
Cardoso, A. I., Sixt, N., Vallier, A., Fayolle, J., Buckland, R., and Wild, T. F. (1998) Measles virus DNA vaccination: antibody
isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen. J. Virol.
72, 2516.
|
| |
| 32. |
Feltquate, D. M., Heaney, S., Webster, R. G., and Robinson, H. L. (1997) Different T helper cell types and antibody isotypes
generated by saline and gene gun DNA immunization. J. Immunol.
158, 2278.
|
| |
| 33. |
Pertmer, T. M., Roberts, T. R., and Haynes, J. R. (1996) Influenza virus nucleoproteinspecific immunoglobulin G subclass and
cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol.
70, 6119.
|
| |
| 34. |
Donnelly, J. J., Ulmer, J. B., and Liu, M. A. (1995) Protective efficacy of intramuscular immunization with naked DNA. Ann. NY Acad. Sci.
772, 40.
|
| |